Zim Laboratories Stock Screener | Share Price & Fundamental Analysis
ZIMLAB
Pharmaceuticals
Screen Zim Laboratories share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹70.33
▼
-0.10 (-0.14%)
Share Price BSE
₹70.15
▼
-0.96 (-1.35%)
Market Cap
₹343.13 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
1.40
EPS (TTM)
₹2.50
Dividend Yield
-
Debt to Equity
0.47
52W High
₹120.82
52W Low
₹67.93
Operating Margin
13.00%
Profit Margin
4.55%
Revenue (TTM)
₹110.00
EBITDA
₹16.00
Net Income
₹5.00
Total Assets
₹472.00
Total Equity
₹252.00
Zim Laboratories Share Price History - Stock Screener Chart
Screen ZIMLAB historical share price movements with interactive charts. Analyze price trends and patterns.
Zim Laboratories Company Profile - Fundamental Screener
Screen Zim Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ZIMLAB shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE518E01015
Zim Laboratories Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen ZIMLAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 472 | 447 | 342 | 342 | 325 | 325 | 329 | 298 | 259 | 256 |
| Current Assets | 231 | 228 | 191 | 212 | 192 | 182 | 194 | 173 | 154 | 154 |
| Fixed Assets | 164 | 161 | 109 | 106 | 107 | 116 | 106 | 94 | 89 | 92 |
| Liabilities | ||||||||||
| Total Liabilities | 472 | 447 | 342 | 342 | 325 | 325 | 329 | 298 | 259 | 256 |
| Current Liabilities | 53 | 49 | 30 | 20 | 22 | 28 | 22 | 20 | 28 | 35 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 252 | 239 | 200 | 176 | 161 | 154 | 151 | 137 | 118 | 99 |
| Share Capital | 49 | 49 | 49 | 16 | 16 | 16 | 16 | 8 | 8 | 8 |
| Reserves & Surplus | 202 | 190 | 152 | 160 | 145 | 138 | 135 | 129 | 110 | 91 |
Screen ZIMLAB income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 110 | 73 | 91 | 119 | 83 | 94 | 98 | 106 | 69 | 87 | 97 | 107 | 95 | 101 | 103 |
| Expenses | 94 | 68 | 83 | 102 | 74 | 83 | 85 | 90 | 63 | 77 | 85 | 90 | 82 | 87 | 88 |
| EBITDA | 16 | 6 | 8 | 17 | 9 | 11 | 13 | 16 | 6 | 11 | 13 | 16 | 13 | 14 | 16 |
| Operating Profit % | 13.00% | 6.00% | 6.00% | 13.00% | 10.00% | 10.00% | 12.00% | 15.00% | 7.00% | 11.00% | 12.00% | 14.00% | 12.00% | 12.00% | 13.00% |
| Depreciation | 5 | 5 | 5 | 4 | 5 | 5 | 5 | 5 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Interest | 3 | 3 | 3 | 2 | 3 | 3 | 3 | 1 | 2 | 1 | 2 | 1 | 1 | 1 | 2 |
| Profit Before Tax | 8 | -2 | 0 | 11 | 1 | 3 | 6 | 10 | 0 | 5 | 7 | 11 | 8 | 8 | 10 |
| Tax | 3 | -1 | 0 | 3 | 0 | 1 | 2 | 3 | 0 | 1 | 2 | 4 | 2 | 3 | 3 |
| Net Profit | 5 | -2 | 0 | 8 | 1 | 2 | 4 | 7 | 0 | 4 | 5 | 7 | 5 | 5 | 7 |
| EPS | 1.01 | -0.38 | -0.09 | 1.66 | 0.18 | 0.49 | 0.82 | 1.48 | 0.05 | 0.85 | 0.98 | 4.33 | 3.17 | 3.35 | 1.35 |
Zim Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen ZIMLAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 41 | 16 | 38 | 49 | 32 | 22 | 35 | 37 | 32 | 22 |
| Investing Activities | -40 | -73 | -36 | -14 | -6 | -19 | -21 | -26 | -7 | -12 |
| Financing Activities | -9 | 60 | 1 | -33 | -26 | -2 | -15 | -10 | -25 | -10 |
| Net Cash Flow | -8 | 3 | 3 | 2 | 0 | 1 | -1 | 1 | 0 | 0 |
Screen ZIMLAB shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% |
| FII Holding | 0.01% | 0.03% | 0.00% | 0.01% | 0.00% | 0.00% | 0.21% | 0.00% |
| DII Holding | 0.24% | 0.24% | 0.24% | 0.00% | 0.11% | 0.10% | 0.24% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 47.78% | 47.50% | 48.20% | 49.01% | 49.21% | 45.48% | 44.39% | 51.57% |
| Other Holding | 18.71% | 18.96% | 18.30% | 17.72% | 17.42% | 21.15% | 21.90% | 15.16% |
| Shareholder Count | 17,448 | 16,641 | 17,282 | 17,100 | 17,483 | 17,716 | 17,450 | 5,879 |
Zim Laboratories Dividend Screener - Share Yield Analysis
Screen ZIMLAB dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Zim Laboratories Index Membership - Market Screener Classification
Screen ZIMLAB by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Zim Laboratories Market Events Screener - Corporate Actions
Screen ZIMLAB market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | 5.86% |
| 2025-08-07 | 2025-08-07 | Quarterly Result Announcement | NA | -29.01% |
| 2025-06-27 | 2025-06-27 | Annual General Meeting | NA | 27.77% |
| 2025-05-20 | 2025-05-20 | Quarterly Result Announcement | NA | 5.18% |
| 2025-02-10 | 2025-02-10 | Quarterly Result Announcement | NA | 5.61% |
| 2024-11-09 | 2024-11-09 | Quarterly Result Announcement | NA | 5.94% |
| 2024-06-27 | 2024-06-27 | Annual General Meeting | NA | 2.64% |
| 2022-12-22 | 2022-12-22 | Bonus | 2:1 | 5.37% |
| 2022-06-29 | 2022-06-29 | Extraordinary General Meeting | NA | -18.24% |
| 2018-10-04 | Bonus | 1:1 | - |
Zim Laboratories Competitors Screener - Peer Comparison
Screen ZIMLAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 416,764 | 40.16 | 54,729 | 9.71% | 10,980 | 41.99 |
| Divis Laboratories | 172,462 | 69.16 | 9,712 | 18.67% | 2,191 | 54.95 |
| Torrent Pharmaceuticals | 129,770 | 60.40 | 11,539 | 6.99% | 1,911 | 64.03 |
| Cipla | 120,864 | 22.30 | 28,410 | 7.12% | 5,291 | 43.36 |
| Dr Reddys Laboratories | 105,645 | 18.66 | 33,741 | 16.73% | 5,725 | 50.22 |
| Lupin | 96,238 | 22.21 | 22,910 | 13.74% | 3,306 | 58.72 |
| Zydus Life Science | 92,352 | 18.57 | 23,511 | 18.55% | 4,615 | 41.66 |
| Mankind Pharma | 90,530 | 51.90 | 12,744 | 20.90% | 2,007 | 47.28 |
| Aurobindo Pharma | 70,358 | 20.66 | 32,346 | 9.43% | 3,484 | 55.09 |
| Alkem Laboratories | 66,550 | 27.75 | 13,458 | 3.70% | 2,216 | 44.89 |
Zim Laboratories Company Announcements - News Screener
Screen ZIMLAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-12-13 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-12-08 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-12-03 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-11-17 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2025-11-15 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-14 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |
| 2025-11-14 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | View |
| 2025-11-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-12 | Results- Quarter And Half Year Ended 30Th September 2025 | View |
| 2025-11-12 | Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th November 2025 | View |
| 2025-11-10 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-05 | Board Meeting Intimation for Considertaion And Approval Of Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Half Year Ended 30Th September 2025 | View |
| 2025-10-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-10-13 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | View |
| 2025-10-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-26 | Closure of Trading Window | View |
| 2025-09-19 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | View |
| 2025-09-19 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-08-14 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |